EBOS Group Limited

EBOSYOTCHealthcare● Active

$24.13

$-1.87(-7.19%)

Market Cap$1.2B

P/E Ratio—

52W High$46.64

52W Low$24.13

Avg Volume88

Open$24.13

Beta0.16

Free Cash Flow Financials Revenue

EBOS Group Limited (EBOSY) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EBOSY · free cash flow · updated Jun 9, 2026

Core FCF metrics

EBOSY · FCF · TTM · margin & CAGR

Free cash flow was $366.0M for FY2025 (fiscal year ending 2025-06-30), up 47.8% year-over-year The FCF margin was 3.0%. Five-year CAGR stands at +11.3%.

FY2025 Free Cash Flow$366.0M▲ +47.8% YoY

Trailing 12M (TTM)$484.9Mtrailing 4 quarters sum

FCF Margin3.0%$366.0M ÷ revenue

3-Year CAGR+27.5%FY2022 → FY2025

5-Year CAGR+11.3%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EBOSY · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$416.1M(50M)$366.0M▲ +47.8%3.0%

FY2024$341.7M(94M)$247.6M▼ 22.4%1.9%

FY2023$396.3M(107M)$318.9M▲ +80.8%2.6%

FY2022$262.2M(99M)$176.4M▼ 24.0%1.5%

FY2021$296.5M(88M)$232.1M▲ +8.5%2.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EBOSY · P/FCF · FCF yield · FCF per share

EBOS Group Limited (EBOSY) trades at a FCF yield of 1.98% and a price-to-free-cash-flow ratio of 2.4x. FCF per share stands at $9.89, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

1.98%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$9.89

TTM FCF ÷ Shares Outstanding

Price / FCF

x2.4

Share Price ÷ FCF per Share

EV / FCF (TTM)

x78.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

EBOSY · cash flow statement · operating / investing / financing

For FY2025, EBOS Group Limited generated $416.1M in operating cash flow and spent 50M in capital expenditures, yielding $366.0M in free cash flow.

Operating Activities

+$416.1M

Cash from core business operations

2025-06-30

Investing Activities

−$366.7M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

−$84.4M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF ($416.1M) − |CapEx| (50M) = FCF ($366.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EBOSY vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

EBOS Group LimitedYOU

EBOSY

$366.0M+47.8%3.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

EBOS Group Limited (EBOSY) reported free cash flow of $366.0M for FY2025 (fiscal year ending 2025-06-30), up 47.8% year-over-year. The FCF margin was 3.0%.

Based on available data, EBOS Group Limited has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $366.0M in FY2025. The 5-year CAGR stands at +11.3%.

EBOS Group Limited's FCF yield is 1.98% and price-to-FCF ratio is 2.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EBOSY free cash flow · 8 questions

EBOS Group Limited free cash flow was $366.0M for FY2025, up 47.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $484.9M.

EBOSY free cash flowEBOSY FCFEBOSY FCF 2025EBOSY free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · EBOS Group Limited · EBOS Group Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026